• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
48,502.41 -615.65
(-1.25%)
Dow Jones
6,987.82 -209.01
(-2.90%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.34 -0.08
(-0.09%)
EUR-INR
102.47 -0.06
(-0.06%)
GBP-INR
122.55 -0.48
(-0.39%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

BSE Sensex Equal Weight
Industry :  Stock Exchanges
BSE Code
ISIN Demat
Book Value()
1200
N.A
0
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
24.81
0
EPS(TTM)
Face Value()
Div & Yield %
0
100
0.93
 

genpharmasec limited
Divi's Laboratories consolidated net profit rises 63.57% in the September 2026 quarter
Nov 07,2026
Net profit of Divi's Laboratories rose 63.57% to Rs 1127.00 crore in the quarter ended September 2026 as against Rs 689.00 crore during the previous quarter ended September 2025. Sales rose 35.40% to Rs 3676.00 crore in the quarter ended September 2026 as against Rs 2715.00 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales3676.002715.00 35
OPM %42.6032.71 -
PBDT1647.001025.00 61
PBT1505.00912.00 65
NP1127.00689.00 64